Effects of donor steatosis on liver biochemistry and significance of body mass index in predicting steatosis

HPB

Volumn 14, Issue 9, 2012, Pages 619-624

  Siriwardana, Rohan C ^a   Chan, See Ching ^a,b   Chok, Kenneth S H ^a   Lo, Chung Mau ^a,b   Fan, Sheung Tat ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b THE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

body mass index; donor hepatectomy; fatty change; liver transplantation; living donor; steatotic donor

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN;

ADULT; ARTICLE; ASIAN; BIOCHEMISTRY; BODY MASS; CONTROLLED STUDY; FATTY LIVER; HEPATIC VEIN; HUMAN; LIVER BIOPSY; LIVER GRAFT; LIVER RESECTION; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; ORGAN DONOR; PREDICTION; PROTHROMBIN TIME; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SAFETY;

EID: 84865126884     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2012.00491.x     Document Type: Article

References (16)

1. Ng KK, Lo CM,. (2009) Liver transplantation in Asia: past, present and future. Ann Acad Med Singapore 38: 322-310.
2. Angulo P,. (2007) GI epidemiology: nonalcoholic fatty liver disease. Aliment Pharmacol Ther 25: 883-889.
3. Bedogni G, Bellentani S,. (2004) Fatty liver: how frequent is it and why? Ann Hepatol 3: 63-65.
4. Cieślak B, Lewandowski Z, Urban M, Ziarkiewicz-Wrõblewska B, Krawczyk M,. (2009) Microvesicular liver graft steatosis as a risk factor of initial poor function in relation to suboptimal donor parameters. Transplant Proc 41: 2985-2988.
5. Marsman WA, Wiesner RH, Rodriguez L, Batts KP, Porayko MK, Hay JE, et al. (1996) Use of fatty donor liver is associated with diminished early patient and graft survival. Transplantation 62: 1246-1251. (Pubitemid 27008548)
6. McCormack L, Petrowsky H, Jochum W, Furrer K, Clavien PA,. (2007) Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy: a matched case-control study. Ann Surg 245: 923-930. (Pubitemid 46809294)
7. Fan ST, Lo CM, Liu CL, Yong BH, Chan JK, Ng IO,. (2000) Safety of donors in live donor liver transplantation using right lobe grafts. Arch Surg 135: 336-340. (Pubitemid 30154577)
8. Soejima Y, Shimada M, Suehiro T, Kishikawa K, Yoshizumi T, Hashimoto K, et al. (2003) Use of steatotic graft in living-donor liver transplantation. Transplantation 76: 344-348. (Pubitemid 36927996)
9. Nagai S, Fujimoto Y, Kamei H, Nakamura T, Kiuchi T,. (2009) Mild hepatic macrovesicular steatosis may be a risk factor for hyperbilirubinaemia in living liver donors following right hepatectomy. Br J Surg 96: 437-444.
10. Chan SC, Fan ST, Liu CL, Lo CM, Lam BK, Lee EW,. (2007) Working up donors for high-urgency and elective adult-to-adult live donor liver transplantation. Liver Transpl 13: 509-515. (Pubitemid 46605852)
11. Seifalian AM, Chidambaram V, Rolles K, Davidson BR,. (1998) In vivo demonstration of impaired microcirculation in steatotic human liver grafts. Liver Transpl Surg 4: 71-77. (Pubitemid 28053314)
12. Ijaz S, Yang W, Winslet MC, Seifalian AM,. (2003) Impairment of hepatic microcirculation in fatty liver. Microcirculation 10: 447-456. (Pubitemid 39004270)
13. Van Ness MM, Diehl AM,. (1989) Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes? Ann Intern Med 111: 473-478. (Pubitemid 19231304)
14. Mazhar SM, Shiehmorteza M, Sirlin CB,. (2009) Noninvasive assessment of hepatic steatosis. Clin Gastroenterol Hepatol 7: 135-140.
15. Rinella ME, Alonso E, Rao S, Whitington P, Fryer J, Abecassis M, et al. (2001) Body mass index as a predictor of hepatic steatosis in living liver donors. Liver Transpl 7: 409-414. (Pubitemid 32492578)
16. Peng CJ, Yuan D, Li B, Wei YG, Yan LN, Wen TF, et al. (2009) Body mass index evaluating donor hepatic steatosis in living donor liver transplantation. Transplant Proc 41: 3556-3559.